NASDAQ:ATRI

Atrion - ATRI Stock Forecast, Price & News

$574.00

+9.00 (+1.59%)

(As of 10/3/2022 05:11 PM ET)

Add

Compare

Today's Range: $566.73
▼
$580.46
50-Day Range: $545.43
▼
$680.30
52-Week Range: $542.10
▼
$805.62

Volume: 6,267 shs
Average Volume: 4,016 shs
Market Capitalization: $1.03 billion

P/E Ratio: 30.23
Dividend Yield: 1.52%
Price Target: N/A

Atrion MarketRank™ Forecast

Analyst Rating: N/A
Upside/Downside: N/A
Short Interest: Bearish
4.51% of Float Sold Short
Dividend Strength: Strong
Based on Four Factors
Sustainability: N/A
News Sentiment: 1.60
Based on 6 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: N/A

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.47 out of 5 stars

Medical Sector

255th out of 1,093 stocks

Surgical & Medical Instruments Industry

30th out of 105 stocks

N/A

Analyst's Opinion

Consensus Rating
There is not enough analysis data for Atrion.

2.0

Short Interest

Percentage of Shares Shorted
4.51% of the float of Atrion has been sold short.
Short Interest Ratio / Days to Cover
Atrion has a short interest ratio ("days to cover") of 18.6, which indicates bearish sentiment.
Change versus previous month
Short interest in Atrion has recently decreased by 3.61%, indicating that investor sentiment is improving.

3.3

Dividend Strength

Dividend Yield
Atrion pays a meaningful dividend of 1.52%, higher than the bottom 25% of all stocks that pay dividends.
Dividend Growth
Atrion has been increasing its dividend for 18 years.
Dividend Coverage
The dividend payout ratio of Atrion is 45.29%. This payout ratio is at a healthy, sustainable level, below 75%.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for ATRI.

3.7

News and Social Media Coverage

News Sentiment
Atrion has a news sentiment score of 1.60. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.84 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 6 news articles for Atrion this week, compared to 0 articles on an average week.
Search Interest
5 people have searched for ATRI on MarketBeat in the last 30 days. This is an increase of 400% compared to the previous 30 days.

3.3

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Atrion insiders have not sold or bought any company stock.
Percentage Held by Insiders
22.65% of the stock of Atrion is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
65.68% of the stock of Atrion is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

1.3

Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of Atrion is 30.51, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 115.83.
Price to Earnings Ratio vs. Sector
The P/E ratio of Atrion is 30.51, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 85.06.
Price to Book Value per Share Ratio
Atrion has a P/B Ratio of 4.27. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Atrion (NASDAQ:ATRI) Stock

Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications in the United States, Canada, Europe, and internationally. Its fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments. The company's cardiovascular products comprise Myocardial Protection System that delivers fluids and medications and mixes critical drugs, as well as controls temperature, pressure, and other variables; cardiac surgery vacuum relief valves; silicone vessel loops for retracting and occluding vessels; and inflation devices for balloon catheter dilation, stent deployment, and fluid dispensing, as well as products for use in heart bypass surgery. Its ophthalmic products include specialized medical devices that disinfect contact lenses; and a line of balloon catheters, which are used for the treatment of nasolacrimal duct obstruction in children and adults. The company also manufactures instrumentation and associated disposables that measure the activated clotting time of blood; and products for safe needle and scalpel blade containment. In addition, it manufactures inflation systems and valves used in marine and aviation safety products; components used in inflatable survival products and structures; and one-way and two-way pressure relief valves that protect sensitive electronics and other products during transport in other medical and non-medical applications. The company sells its products to physicians, hospitals, clinics, and other treatment centers; and other equipment manufacturers through direct sales force, independent sales representatives, and distributors. Atrion Corporation was founded in 1944 and is headquartered in Allen, Texas.

Receive ATRI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Atrion and its competitors with MarketBeat's FREE daily newsletter.

ATRI Stock News Headlines

October 3, 2022 | finance.yahoo.com

Plurilock's Aurora Systems Receives US$2.8 Million 3-year Purchase Order from a U.S. Food, Facilities, and Uniform Services Provider

September 27, 2022 | proactiveinvestors.com

Plurilock Security earns repeat ‘Buy’ rating from broker Leede Jones Gable after closing of Atrion Communications asset acquisition

September 26, 2022 | finance.yahoo.com

Plurilock's Aurora Announces Closing of Asset Purchase Agreement with Atrion Communications, Inc.

September 15, 2022 | finance.yahoo.com

Atrion (NASDAQ:ATRI) investors are sitting on a loss of 21% if they invested three years ago

September 14, 2022 | nasdaq.com

Ex-Dividend Reminder: NorthWestern, Atrion and Merck

September 8, 2022 | seekingalpha.com

Atrion: Attractively Priced For Exposure To Defensive Healthcare

August 27, 2022 | marketwatch.com

Atrion Taps Cindy Ferguson to Serve as CFO Following Jeffery Strickland's Retirement

August 26, 2022 | finance.yahoo.com

Atrion's (NASDAQ:ATRI) Dividend Will Be Increased To $2.15

August 25, 2022 | finance.yahoo.com

Atrion Corporation Announces CFO Succession Plan

August 22, 2022 | marketwatch.com

Atrion Corp. Raises Dividend by 10%

August 22, 2022 | finance.yahoo.com

Atrion Corporation Increases Quarterly Cash Dividend by 10%

August 9, 2022 | reuters.com

ATRI.O - Atrion Corporation | Stock Price & Latest News | Reuters

August 9, 2022 | proactiveinvestors.com

Plurilock Security announces asset purchase agreement with Atrion Communications

August 9, 2022 | proactiveinvestors.com

Plurilock Security to acquire certain assets of cybersecurity solutions provider Atrion

August 9, 2022 | finance.yahoo.com

Plurilock's Aurora Systems Announces Signing of an Asset Purchase Agreement with Atrion Communications, Inc.

August 8, 2022 | finance.yahoo.com

Atrion Reports Second Quarter 2022 Results

June 22, 2022 | finance.yahoo.com

Returns On Capital At Atrion (NASDAQ:ATRI) Paint A Concerning Picture

May 9, 2022 | finance.yahoo.com

Atrion Reports First Quarter 2022 Results

April 4, 2022 | finance.yahoo.com

Those who invested in Atrion (NASDAQ:ATRI) five years ago are up 59%

February 25, 2022 | seekingalpha.com

Atrion declares $1.95 dividend

February 25, 2022 | apnews.com

Atrion: Q4 Earnings Snapshot

February 25, 2022 | finance.yahoo.com

Atrion Reports Fourth Quarter and Full Year 2021 Results

February 21, 2022 | reuters.com

Atrion Corporation

February 18, 2022 | finance.yahoo.com

What Type Of Shareholders Own The Most Number of Atrion Corporation (NASDAQ:ATRI) Shares?

January 16, 2022 | nasdaq.com

Atrion (NASDAQ:ATRI) May Have Issues Allocating Its Capital

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive ATRI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Atrion and its competitors with MarketBeat's FREE daily newsletter.

ATRI Company Calendar

Last Earnings: 8/08/2022
Ex-Dividend for 9/30 Dividend: 9/14/2022
Dividend Payable: 9/30/2022
Today: 10/03/2022
Next Earnings (Estimated): 11/14/2022
Fiscal Year End: 12/31/2022

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Surgical & medical instruments
Sub-Industry: Health Care Supplies
Sector: Medical
Current Symbol: NASDAQ:ATRI
CUSIP: 04990410
CIK: 701288
Web: www.atrioncorp.com
Phone: (972) 390-9800
Fax: 972-396-7581
Employees: 667
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): $18.99
Trailing P/E Ratio: 30.23
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $33.06 million
Net Margins: 19.12%
Pretax Margin: 22.02%
Return on Equity: 14.03%
Return on Assets: 12.65%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 7.14
Quick Ratio: 4.32

Sales & Book Value

Annual Sales: $165.01 million
Price / Sales: 6.21
Cash Flow: $25.91 per share
Price / Cash Flow: 22.15
Book Value: $135.67 per share
Price / Book: 4.23

Miscellaneous

Outstanding Shares: 1,786,000
Free Float: 1,381,000
Market Cap: $1.03 billion
Optionable: Not Optionable
Beta: 0.26

Key Executives

Mr. Emile A. Battat (Age 84)
Exec. Chairman
Comp: $666.55k

Mr. David A. Battat (Age 52)
Pres & CEO
Comp: $1.94M

Mr. Jeffery Strickland (Age 63)
CFO, VP, Treasurer & Sec.
Comp: $986.38k

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

ATRI Stock - Frequently Asked Questions

How have ATRI shares performed in 2022?: Atrion's stock was trading at $704.90 on January 1st, 2022. Since then, ATRI shares have decreased by 19.5% and is now trading at $567.54.
View the best growth stocks for 2022 here.
When is Atrion's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Monday, November 14th 2022.
View our ATRI earnings forecast.
How were Atrion's earnings last quarter?: Atrion Co. (NASDAQ:ATRI) released its earnings results on Monday, August, 8th. The medical instruments supplier reported $5.20 earnings per share for the quarter. The medical instruments supplier had revenue of $48.88 million for the quarter. Atrion had a trailing twelve-month return on equity of 14.03% and a net margin of 19.12%.
How often does Atrion pay dividends? What is the dividend yield for Atrion?: Atrion declared a quarterly dividend on Monday, August 22nd. Stockholders of record on Thursday, September 15th will be given a dividend of $2.15 per share on Friday, September 30th. This represents a $8.60 annualized dividend and a dividend yield of 1.52%. The ex-dividend date is Wednesday, September 14th. This is an increase from the stock's previous quarterly dividend of $1.95.
Read our dividend analysis for ATRI.
Is Atrion a good dividend stock?: Atrion (NASDAQ:ATRI) pays an annual dividend of $8.60 per share and currently has a dividend yield of 1.52%. The company has been increasing its dividend for 18 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 45.29%. This payout ratio is at a healthy, sustainable level, below 75%.
Read our dividend analysis for ATRI.
What is David A. Batta's approval rating as Atrion's CEO?: 1 employees have rated Atrion Chief Executive Officer David A. Batta on Glassdoor.com. David A. Batta has an approval rating of 100% among the company's employees. This puts David A. Batta in the top 10% of approval ratings compared to other CEOs of publicly-traded companies. 100.0% of employees surveyed would recommend working at Atrion to a friend.

What other stocks do shareholders of Atrion own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Atrion investors own include International Paper (IP), AT&T (T), WestRock (WRK), AbbVie (ABBV), Caterpillar (CAT), Eastman Chemical (EMN), Gilead Sciences (GILD), Altria Group (MO), Pfizer (PFE) and Philip Morris International (PM).
What is Atrion's stock symbol?: Atrion trades on the NASDAQ under the ticker symbol "ATRI."
How do I buy shares of Atrion?: Shares of ATRI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Atrion's stock price today?: One share of ATRI stock can currently be purchased for approximately $567.54.
How much money does Atrion make?: Atrion (NASDAQ:ATRI) has a market capitalization of $1.01 billion and generates $165.01 million in revenue each year. The medical instruments supplier earns $33.06 million in net income (profit) each year or $18.99 on an earnings per share basis.
How many employees does Atrion have?: The company employs 667 workers across the globe.
How can I contact Atrion?: Atrion's mailing address is ONE ALLENTOWN PARKWAY, ALLEN TX, 75002. The official website for the company is www.atrioncorp.com. The medical instruments supplier can be reached via phone at (972) 390-9800, via email at ir-info@atrioncorp.com, or via fax at 972-396-7581.

This page (NASDAQ:ATRI) was last updated on 10/3/2022 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Atrion - ATRI Stock Forecast, Price & News

Atrion MarketRank™ Forecast

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

News and Social Media Coverage

News Sentiment

News Coverage This Week

Search Interest